PTC Therapeutics Inc (PTCT) - Financial and Strategic SWOT Analysis Review

PTC Therapeutics Inc (PTCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

PTC Therapeutics Inc (PTC Therapeutics) discovers, develops, and markets medicines for the treatment of rare disorders. Its marketed products include Translarna (ataluren) and Emflaza (deflazacort) are indicated for the treatment of Duchenne muscular dystrophy. The companys pipeline candidates include PTC596 for the treatment of leiomyosarcoma; PTC299 for the treatment of acute myelogenous leukemia; and PTC-AADC for the treatment of aromatic L-amino acid decarboxylase deficiency. PTC Therapeutics works in collaboration with various biotechnology and pharmaceutical companies for advancing its pipeline candidates. The company operates through its subsidiaries in Europe. PTC Therapeutics is headquartered in South Plainfield, New Jersey, the US.

PTC Therapeutics Inc Key Recent Developments

May 06,2020: PTC Therapeutics to acquire Censa Pharmaceuticals
Apr 30,2020: PTC Therapeutics reports first quarter 2020 financial results and provides a corporate update
Apr 17,2020: PTC Therapeutics announces new leadership appointments
Mar 16,2020: PTC Therapeutics announces management change
Mar 02,2020: PTC Therapeutics reports fourth quarter and full year 2019 financial results and provides a corporate update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 


Section 1 - About the Company
PTC Therapeutics Inc - Key Facts
PTC Therapeutics Inc - Key Employees
PTC Therapeutics Inc - Key Employee Biographies
PTC Therapeutics Inc - Major Products and Services
PTC Therapeutics Inc - History
PTC Therapeutics Inc - Company Statement
PTC Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
PTC Therapeutics Inc - Business Description
Product Category: Collaboration and Grant Revenue
Performance
Product Category: Net Product Revenue
Performance
Geographical Segment: Non-US
Performance
Geographical Segment: The US
Performance
R&D Overview
PTC Therapeutics Inc - Corporate Strategy
PTC Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
PTC Therapeutics Inc - Strengths
PTC Therapeutics Inc - Weaknesses
PTC Therapeutics Inc - Opportunities
PTC Therapeutics Inc - Threats
PTC Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
PTC Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 30, 2020: PTC Therapeutics reports first quarter 2020 financial results and provides a corporate update
Apr 17, 2020: PTC Therapeutics announces new leadership appointments
Mar 16, 2020: PTC Therapeutics announces management change
Mar 02, 2020: PTC Therapeutics reports fourth quarter and full year 2019 financial results and provides a corporate update
Jan 13, 2020: PTC Therapeutics provides corporate update and highlights pipeline progress at 2020 J.P. Morgan Healthcare Conference
Oct 29, 2019: PTC Therapeutics reports third quarter 2019 financial results and provides a corporate update
Aug 06, 2019: PTC Therapeutics reports second quarter 2019 financial results and provides a corporate update
Aug 05, 2019: PTC Therapeutics expands presence in New Jersey by securing State-of-the-Art Biologics Facility
Jun 03, 2019: PTC Therapeutics promotes Emily Hill to Chief Financial Officer
May 20, 2019: PTC Therapeutics announces first-ever winners of its PRIORITY program to support research projects in rare, genetic disorders
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
 


List Of Tables


PTC Therapeutics Inc, Key Facts
PTC Therapeutics Inc, Key Employees
PTC Therapeutics Inc, Key Employee Biographies
PTC Therapeutics Inc, Major Products and Services
PTC Therapeutics Inc, History
PTC Therapeutics Inc, Other Locations
PTC Therapeutics Inc, Subsidiaries
PTC Therapeutics Inc, Key Competitors
PTC Therapeutics Inc, Ratios based on current share price
PTC Therapeutics Inc, Annual Ratios
PTC Therapeutics Inc, Annual Ratios (Cont...1)
PTC Therapeutics Inc, Interim Ratios
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
PTC Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures


PTC Therapeutics Inc, Performance Chart (2015 - 2019)
PTC Therapeutics Inc, Ratio Charts
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
 


PTC India Ltd (PTC) - Financial and Strategic SWOT Analysis Review

PTC India Ltd (PTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Pakistan Telecommunication Company Ltd (PTC) - Financial and Strategic SWOT Analysis Review

Pakistan Telecommunication Company Ltd (PTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

USD 125 View Report

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2021 Update

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for degenerative orthopedic diseases and traumatic conditions. It offers solutions for ortho-biologics, dermal, ophthalmic, surgical and veterinary applications. Its major

USD 750 View Report

Chinook Therapeutics Inc (KDNY) - Financial and Strategic SWOT Analysis Review

Chinook Therapeutics, Inc (Chinook)., formerly Aduro BioTech Inc is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available